لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lyon RP; Seagen Inc., Bothell, Washington., Jonas M; Seagen Inc., Bothell, Washington., Frantz C; Seagen Inc., Bothell, Washington., Trueblood ES; Seagen Inc., Bothell, Washington., Yumul R; Seagen Inc., Bothell, Washington., Westendorf L; Seagen Inc., Bothell, Washington., Hale CJ; Seagen Inc., Bothell, Washington., Stilwell JL; Seagen Inc., Bothell, Washington., Yeddula N; Seagen Inc., Bothell, Washington., Snead KM; Seagen Inc., Bothell, Washington., Kumar V; Seagen Inc., Bothell, Washington., Patilea-Vrana GI; Seagen Inc., Bothell, Washington., Klussman K; Seagen Inc., Bothell, Washington., Ryan MC; Seagen Inc., Bothell, Washington.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Dec 01; Vol. 22 (12), pp. 1444-1453.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Immunoconjugates*/pharmacology , Immunoconjugates*/therapeutic use , Antineoplastic Agents* , Carcinoma*, Humans ; Prognosis ; Integrins ; Cell Line, Tumor

المؤلفون: Ramirez AB; RareCyte, Inc., Seattle, WA, USA., Bhat R; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., Sahay D; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Thangavel H; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., Hedayatpour S; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., Dobrolecki LE; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Nardone A; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Nagi C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Rimawi M; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Lewis MT; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Stilwell JL; RareCyte, Inc., Seattle, WA, USA., Kaldjian EP; RareCyte, Inc., Seattle, WA, USA., Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. rschiff@bcm.edu., Trivedi MV; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA. mtrivedi@central.uh.edu.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. mtrivedi@central.uh.edu.

المصدر: BMC cancer [BMC Cancer] 2019 Mar 12; Vol. 19 (1), pp. 220. Date of Electronic Publication: 2019 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Breast Neoplasms/*metabolism , Class I Phosphatidylinositol 3-Kinases/*genetics , Neoplastic Cells, Circulating/*metabolism , Single-Cell Analysis/*methods, Animals ; Antineoplastic Agents/pharmacology ; Biomarkers, Tumor/blood ; Breast Neoplasms/drug therapy ; Cell Line, Tumor ; Cell Separation ; Class I Phosphatidylinositol 3-Kinases/blood ; Female ; Humans ; Keratins/blood ; Leukocyte Common Antigens/blood ; Mice ; Mice, SCID ; Mutation ; Neoplasm Transplantation ; Neoplastic Cells, Circulating/drug effects ; Sequence Analysis, DNA

المؤلفون: Ramirez AB; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., U'Ren L; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Campton DE; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Stewart D; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Nordberg JJ; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Stilwell JL; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Kaldjian EP; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA. ekaldjian@rarecyte.com.

المصدر: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2017; Vol. 1634, pp. 163-172.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE

مواضيع طبية MeSH: Cell Separation/*methods , Cells, Immobilized/*pathology , Neoplasms/*diagnosis , Neoplastic Cells, Circulating/*pathology , Single-Cell Analysis/*methods, Cell Count ; Cell Line, Tumor ; Cell Separation/instrumentation ; Cells, Immobilized/metabolism ; Centrifugation/instrumentation ; Centrifugation/methods ; Equipment Design ; Humans ; Neoplasms/blood ; Neoplasms/pathology ; Neoplastic Cells, Circulating/metabolism ; Reagent Kits, Diagnostic/standards ; Single-Cell Analysis/instrumentation